US OptionsDetailed Quotes
SLDB250117C7500
- 0.05
- 0.000.00%
15min DelayClose Jan 7 16:00 ET
0.00High0.00Low
0.05Open0.05Pre Close0 Volume759 Open Interest7.50Strike Price0.00Turnover244.42%IV92.60%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier10DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.0809Delta0.0946Gamma78.40Leverage Ratio-0.0114Theta0.0001Rho6.34Eff Leverage0.0010Vega
Solid Biosciences Stock Discussion
Solid Biosciences Announces FDA IND Clearance for First-In-Industry Dual Route of Administration Gene Therapy to Treat Both Neurologic and Cardiac Manifestations of Friedreich's Ataxia
Tuesday, 7th January at 4:15 pm
- SGT-212 is the only full-length frataxin replacement gene therapy candidate targeting the CNS and cardiac manifestations of Friedreich's ataxia -
- Dual route of administration enables direct delivery of AAV-based gene therapy to the cerebellum and...
RA capital and perspective advisors are both investors here. They also are invested in $Bright Minds Biosciences (DRUG.US)$
DRUG ran recently as we all know but also ran 3000% in 2022. Each time RA Capital and perspective advisors were invested and both times there were private placements after they ran.
In 2021 SLDB ran 450%, RA Capital and perspective advisors both invested and a private placement after it ran.
SLDB has not had a major run since but maybe it will a...
» Holdings in Top 20: 58.46%
» Qtr over Qtr Change**: 28.47%
Top Holdings:
$Cerevel Therapeutics Holdings (CERE.US)$
$Amicus Therapeutics (FOLD.US)$
$Iovance Biotherapeutics (IOVA.US)$
$Arcellx (ACLX.US)$
$Nuvalent (NUVL.US)$
$Apogee Therapeutics (APGE.US)$
$Inhibrx (INBX.US)$
$Fusion Pharmaceuticals (FUSN.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Vaxcyte (PCVX.US)$
$Soleno Therapeutics (SLNO.US)$
$Medtronic (MDT.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
...
Moomoo 24/7· 1 min ago
No comment yet